This supplement reviews two posters presented at the ‘Liver Meeting®’ 2021. Both posters delved into new trial data on the efficacy of Aramchol™ to treat non-alcoholic steatohepatitis, analysing biopsy outcomes, fibrosis improvement, and biomarker data.
Login to continue
Members
Create Account
Create your own personal healthcare feed, full of the latest content from across our divisions.
Register
